Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: herpes zoster

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 9, 2012

Information on new approvals and medication safety.

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing SpondylitisBiologicsbiophosphonatesdrugJAK inhibitorsjanus kinaseMethotrexateopioidPainRheumatoid arthritisrheumatologistrituximabSafetySystemic lupus erythematosustocilizumabTofacitinib

ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA

Kathy Holliman  |  June 10, 2012

Detailed screening and treatment recommendations based on current evidence, extensive literature review.

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesFrom the CollegeRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugGlucocorticoidsGuidelinesLupusLupus nephritispatient careRheumatoid arthritisSystemic lupus erythematosustocilizumab

Shingles, Chickenpox Hospitalizations Higher for Patients on Anti-TNF Drugs

By Sue Pondrom  |  December 22, 2010

More research needed to clarify risks and benefits of VZV vaccination

Filed under:Research Rheum Tagged with:LiteratureResearchtumor necrosis factorvaricella zoster virus

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsPipline

Drug Updates

From the College  |  July 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug UpdatesFrom the College Tagged with:ApprovalsBiologicsJuvenile arthritisPipline

Immunizations in Immunocomprised Patients

Gretchen Henkel  |  August 1, 2009

Vaccines can help minimize certain diseases

Filed under:ConditionsDrug Updates Tagged with:ACR/ARHP Annual MeetingDiagnosisImmunizationTreatmentvaccination

Is It Behcet’s? Review Course Offers Diagnosis Tips

Samantha C. Shapiro, MD  |  December 5, 2024

WASHINGTON, D.C.—Behçet’s disease (BD) is not a common condition, but we frequently receive referrals to evaluate for it in rheumatology clinics because a patient has oral or genital ulcers. So what’s Behçet’s and what’s not? How can we tell the difference? At the ACR Convergence 2024 Review Course, Johannes Nowatzky, MD, director, New York University…

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024Behçet’s disease

Case Report: Dermato-Neuro Syndrome Recurrence after a Viral Infection

Case Report: Dermato-Neuro Syndrome Recurrence after a Viral Infection

Fazila Aseem, MD, MPH, Alexander D. Jeffs, MD, Enid Y. Sun, MD, MPH, Randaline R. Barnett, MD, Courtney Blodgett, AG-ACNP, Winnie Lau, MD, Casey Olm-Shipman, MD, MS, Matthew F. Sharrock, MD, Rhonda Cadena, MD, Yueh. Z. Lee, MD, PhD, Alfredo C. Rivadeneira, MD, & Clio A. Rubinos, MD, MS  |  July 13, 2022

Scleromyxedema is a primary cutaneous mucinosis characterized by a diffuse and generalized papular skin eruption of mucinous deposits throughout the upper dermis. In addition to dermatologic manifestations, scleromyxedema may involve the cardiopulmonary, gastrointestinal, renal and nervous systems. Dermato-neuro syndrome (DNS) is a rare, severe neurologic complication of scleromyxedema.1,2 The pathogenesis of DNS is unknown, but…

Filed under:ConditionsSystemic Sclerosis Tagged with:case reportCOVID-19Dermato-Neuro SyndromeFellowsScleromyxedema

The Link Between Takayasu’s Arteritis & Increased Stroke Risk

Lara C. Pullen, PhD  |  March 26, 2018

Approximately 16% of patients diagnosed with Takayasu’s arteritis (TA) experience a stroke. In a recent study, researchers found patients with TA and stroke had higher levels of C-reactive protein at diagnosis…

Filed under:Conditions Tagged with:brainstrokeTakayasu’s Arteritis

Fellows Forum Case Report: Neuromyelitis Optica

Atul Kapila, MD, Tayseer Haroun, MBBS, & Jayanth Doss, MD  |  April 19, 2017

Case Presentation The patient was a 42-year-old African American female diagnosed with systemic lupus erythematosus (SLE) based on the findings of polyarthritis, malar and discoid rash, fatigue, positive double-stranded DNA (dsDNA) ribonucleoprotein and Smith antibodies, and low serum complement levels. Her SLE had been well controlled on hydroxychloroquine 400 mg daily, oral methotrexate 25 mg…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:case reportcentral nervous systemClinicalDevic's diseaseDiagnosiseyeFellowsFellows Foruminflammatory syndromeneuromyelitis opticaoutcomerheumatologyTreatmentvision

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences